BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-04 7:49 pm Sale | 2024-12-04 | 13D | Olema Pharmaceuticals, Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 7,557,237 9.990% | -1,578,656 (-17.28%) | Filing |
| 2023-09-14 4:23 pm Purchase | 2023-09-12 | 13D | Olema Pharmaceuticals, Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 9,135,893 16.700% | 1,724,390 (+23.27%) | Filing |
| 2021-12-02 5:05 pm Purchase | 2021-11-30 | 13D | Olema Pharmaceuticals, Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 7,411,503 18.400% | 750,000 (+11.26%) | Filing |
| 2020-11-20 5:23 pm Purchase | 2020-11-19 | 13D | Olema Pharmaceuticals, Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 6,661,503 16.600% | 6,661,503 (New Position) | Filing |